Tai Yin Yang
Directeur/Membre du Conseil chez KODIAK SCIENCES INC.
Fortune : 11 106 $ au 30/04/2024
Profil
Tai Yin Yang is currently an Independent Director at Kodiak Sciences, Inc., Kronos Bio, Inc., and Brii Biosciences Ltd.
(China).
They are also a Member of the American Chemical Society, the National Academy of Engineering, the American Association of Pharmaceutical Scientists, and the Drug Information Association.
Additionally, they serve as a Scientific Advisor at Sionna Therapeutics, Inc. In the past, Dr. Yang worked as a Director-Analytical Chemistry at Syntex Corp.
They also held the position of EVP-Pharmaceutical Development & Manufacturing at Gilead Sciences, Inc. from 2015 to 2022.
Dr. Yang holds a doctorate degree from the University of Southern California and an undergraduate degree from National Taiwan University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
KRONOS BIO INC
0,02% | 31/03/2024 | 11 333 ( 0,02% ) | 11 106 $ | 30/04/2024 |
KODIAK SCIENCES, INC.
-.--% | 01/04/2024 | 0 ( -.--% ) | - $ | 30/04/2024 |
Postes actifs de Tai Yin Yang
| Sociétés | Poste | Début |
|---|---|---|
| KODIAK SCIENCES INC. | Directeur/Membre du Conseil | 17/12/2019 |
| KRONOS BIO, INC. | Directeur/Membre du Conseil | 25/03/2021 |
| BRII BIOSCIENCES LIMITED | Directeur/Membre du Conseil | 01/09/2022 |
American Association of Pharmaceutical Scientists
 American Association of Pharmaceutical Scientists BiotechnologyHealth Technology The American Association of Pharmaceutical Scientists engages in research and development of pharmaceutical products. The private company is based in Arlington, VA. The company was founded by Leslie Z. Benet. | Corporate Officer/Principal | - |
American Chemical Society
 American Chemical Society Miscellaneous Commercial ServicesCommercial Services American Chemical Society engages as a scientific society which supports scientific inquiry in the field of chemistry. The company was founded in 1876 and is headquartered in Washington, DC. | Corporate Officer/Principal | - |
Drug Information Association
 Drug Information Association Miscellaneous Commercial ServicesCommercial Services The Drug Information Association is a non-profit multidisciplinary association that operates to promote health and well-being. The non-profit company is based in Horsham, PA. Marwan Fathallah has been the CEO of the company since 2023. | Corporate Officer/Principal | - |
National Academy of Engineering
 National Academy of Engineering Miscellaneous Commercial ServicesCommercial Services Part of The National Academies of Science, the National Academy of Engineering operates as a professional membership organization. The company is based in Washington. | Corporate Officer/Principal | 01/01/2022 |
Sionna Therapeutics, Inc.
 Sionna Therapeutics, Inc. Medical/Nursing ServicesHealth Services Sionna Therapeutics, Inc. is a clinical-stage life sciences company located in Natick, MA. The company is dedicated to developing highly effective and differentiated treatments for cystic fibrosis (CF) by normalizing the function of CFTR, the key protein associated with disease progression in CF. Sionna is advancing a pipeline of small molecules engineered to correct the protein defects caused by ?F508, the most common mutation that affects the CFTR protein. The company has a first-in-class portfolio of programs directly targeting correction of ?F508-CFTR, the key and unique mechanism to enable full restoration of ?F508-CFTR function, and complementary programs targeting ICL4 and more. The CEO of the company is Michael Cloonan. | Corporate Officer/Principal | - |
Anciens postes connus de Tai Yin Yang
| Sociétés | Poste | Fin |
|---|---|---|
| GILEAD SCIENCES, INC. | Corporate Officer/Principal | 18/07/2022 |
| ░░░░░░ ░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Formation de Tai Yin Yang
| National Taiwan University | Undergraduate Degree |
| University of Southern California | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 4 |
|---|---|
| GILEAD SCIENCES, INC. | Health Technology |
| KODIAK SCIENCES INC. | Health Technology |
| KRONOS BIO, INC. | Health Technology |
| BRII BIOSCIENCES LIMITED | Commercial Services |
| Entreprise privées | 6 |
|---|---|
American Association of Pharmaceutical Scientists
American Association of Pharmaceutical Scientists BiotechnologyHealth Technology The American Association of Pharmaceutical Scientists engages in research and development of pharmaceutical products. The private company is based in Arlington, VA. The company was founded by Leslie Z. Benet. | Health Technology |
American Chemical Society
American Chemical Society Miscellaneous Commercial ServicesCommercial Services American Chemical Society engages as a scientific society which supports scientific inquiry in the field of chemistry. The company was founded in 1876 and is headquartered in Washington, DC. | Commercial Services |
Drug Information Association
Drug Information Association Miscellaneous Commercial ServicesCommercial Services The Drug Information Association is a non-profit multidisciplinary association that operates to promote health and well-being. The non-profit company is based in Horsham, PA. Marwan Fathallah has been the CEO of the company since 2023. | Commercial Services |
| Syntex Corp. | Health Technology |
National Academy of Engineering
National Academy of Engineering Miscellaneous Commercial ServicesCommercial Services Part of The National Academies of Science, the National Academy of Engineering operates as a professional membership organization. The company is based in Washington. | Commercial Services |
Sionna Therapeutics, Inc.
Sionna Therapeutics, Inc. Medical/Nursing ServicesHealth Services Sionna Therapeutics, Inc. is a clinical-stage life sciences company located in Natick, MA. The company is dedicated to developing highly effective and differentiated treatments for cystic fibrosis (CF) by normalizing the function of CFTR, the key protein associated with disease progression in CF. Sionna is advancing a pipeline of small molecules engineered to correct the protein defects caused by ?F508, the most common mutation that affects the CFTR protein. The company has a first-in-class portfolio of programs directly targeting correction of ?F508-CFTR, the key and unique mechanism to enable full restoration of ?F508-CFTR function, and complementary programs targeting ICL4 and more. The CEO of the company is Michael Cloonan. | Health Services |